NOV 14, 2017 10:00 AM PST

WEBINAR: Cancer Cells Send Signals Boosting Survival and Drug Resistance in Other Cancer Cells

Speaker
  • Postdoctoral Researcher, UCSD
    Biography
      Jeffrey is an expert in tumor microenvironment biology. Currently a postdoctoral researcher, he completed his PhD in Biomedical Sciences at UC San Diego focused on the unfolded protein response (UPR) within the tumor microenvironment. His research involved elucidating how the tumor microenvironment becomes dysregulated within both the cancer cell and immune infiltrate compartments through the production of signaling molecules cancers cells producing during the UPR.
      He earned his BS in Bioengineering : (Biotechnology) from UC San Diego in 2010 where he performed research in the fields of biomaterials and stem cell mechanotransduction.

    Abstract

    DATE: November 14, 2017
    TIME: 10:00am PST, 1:00pm EST

    Successful tumor outgrowth requires the coordination of a variety of cell intrinsic and cell extrinsic signaling events. These events include those establishing a tumor microenvironment (TME) that both enables tumor cell survival and disables anti-tumor immunity. Recent reports demonstrate that these events require molecules produced by resident tumor cells. Tumor-borne signals within the tumor microenvironment propagate tumor cell fitness and immune hijacking. The endoplasmic reticulum (ER) stress is an adaptive response to a variety of TME insults, including hypoxia and nutrient deprivation, raising the possibility that ER stress could serve as a potential source of tumor cell fitness and immune dysregulation. To that end, we induced cancer cells of various origin to undergo ER stress and harvested the resulting conditioned medium (CM) to explore its effects on both recipient cancer cells and immune cells. Cell culture medium became an invaluable tool to our studies as it allowed us to recreate stimuli existent within the tumor microenvironment under controlled conditions. Our results revealed that the CM of cancer cells undergoing ER stress transmits ER stress to recipient cells. On the one hand, myeloid cells (macrophages and dendritic cells) treated with the CM of ER stressed cancer cells acquire a mixed pro-inflammatory and immune suppressive phenotype, which restrained T cell anti-tumor immunity and facilitated tumor growth in vivo. On the other hand, cancer cells treated with the CM of ER stressed cancer cells acquire cellular fitness to a variety of challenges including nutrient deprivation and chemotherapies. When implanted into immune competent hosts, ER stress experienced cancer cells grew at markedly faster rates than inexperienced ones. These findings support the existence of a novel mechanism used by tumor cells to restrain anti-tumor immunity while enhancing cellular fitness with the TME.

    Learning Objectives:

    • Understand how to design an in vitro system to model phenomenon within the tumor microenvironment
    • Understand how ER stress in cancer cells may facilitate immune dysregulation and chemoresistance in vivo

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    APR 21, 2021 5:00 PM CEST
    APR 21, 2021 5:00 PM CEST
    Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
    NOV 14, 2017 10:00 AM PST

    WEBINAR: Cancer Cells Send Signals Boosting Survival and Drug Resistance in Other Cancer Cells


    Specialty

    Cancer Research

    Molecular Biology

    Cell Biology

    Cancer Therapeutics

    Immunology

    Biotechnology

    Cancer Diagnostics

    Cell Culture

    Genetics

    Biomarkers

    Molecular Diagnostics

    Oncology

    Biochemistry

    Clinical Research

    Clinical Diagnostics

    Geography

    North America59%

    Europe21%

    Asia11%

    South America4%

    Africa3%

    Registration Source

    Website Visitors100%

    Job Title

    Student21%

    Research Scientist20%

    Educator/Faculty10%

    Scientist9%

    Post Doc7%

    Executive7%

    Medical Laboratory Technician7%

    Medical Doctor/Specialist6%

    Facility/Department Manager5%

    Lab Management4%

    Clinical Laboratory Scientist4%

    Biologist1%

    Organization

    Academic Institution13%

    Research Institute8%

    Hospital7%

    Biotech Company6%

    Clinical Laboratory5%

    Medical School3%

    Ambulatory Care3%

    Pharmaceutical Company2%

    Government2%

    Medical Center2%

    Life Science Company1%

    Consultant1%

    Contract Research Organization (Cro)1%

    Non-Profit Organization1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more